BORGIA, GUGLIELMO
 Distribuzione geografica
Continente #
NA - Nord America 3.660
EU - Europa 1.931
AS - Asia 1.779
AF - Africa 59
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 7.445
Nazione #
US - Stati Uniti d'America 3.509
SG - Singapore 778
IT - Italia 614
CN - Cina 583
HK - Hong Kong 378
NL - Olanda 296
FI - Finlandia 212
RU - Federazione Russa 206
DE - Germania 173
IE - Irlanda 170
CA - Canada 146
UA - Ucraina 94
GB - Regno Unito 53
CI - Costa d'Avorio 50
SE - Svezia 42
FR - Francia 20
CH - Svizzera 18
IN - India 16
BR - Brasile 11
CZ - Repubblica Ceca 9
EG - Egitto 8
TR - Turchia 7
AT - Austria 6
BE - Belgio 5
MX - Messico 5
IR - Iran 4
EU - Europa 3
RS - Serbia 3
VN - Vietnam 3
BG - Bulgaria 2
ID - Indonesia 2
LU - Lussemburgo 2
PH - Filippine 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
CL - Cile 1
DZ - Algeria 1
ES - Italia 1
JP - Giappone 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MK - Macedonia 1
PK - Pakistan 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 7.445
Città #
Singapore 643
Chandler 606
Hong Kong 378
Santa Clara 301
Amsterdam 282
Millbury 282
Princeton 198
Nanjing 188
Naples 177
Ottawa 137
Jacksonville 114
Ashburn 106
Napoli 104
Beijing 90
Boston 90
Des Moines 85
Wilmington 69
Nanchang 64
Boardman 50
Hebei 40
Jiaxing 38
Shenyang 34
Ann Arbor 33
Seattle 33
Krefeld 31
Woodbridge 31
Lawrence 28
Houston 27
Tianjin 27
Helsinki 25
Norwalk 21
Changsha 18
Basel 17
Indiana 14
Los Angeles 13
Falkenstein 11
Falls Church 11
Caserta 10
Nuremberg 10
Dublin 8
Hangzhou 8
Pomigliano D'arco 8
Boise 7
Brno 7
Dallas 7
Kunming 7
Mugnano di Napoli 7
Munich 7
Washington 7
Changchun 6
Kronberg 6
Orange 6
Redmond 6
Toronto 6
Fisciano 5
Jinan 5
New York 5
Pune 5
Bologna 4
Brescia 4
Brussels 4
Cairo 4
Castellammare di Stabia 4
Mexico City 4
Shanghai 4
Acerra 3
Agropoli 3
Bari 3
Campagna 3
Cercola 3
Chicago 3
Dung 3
Edinburgh 3
Florence 3
Guangzhou 3
Lanzhou 3
Marseille 3
Milan 3
Mumbai 3
Palermo 3
Redwood City 3
Richland 3
Rome 3
Shenzhen 3
Zhengzhou 3
Acquaviva Delle Fonti 2
Augusta 2
Chandigarh 2
Chions 2
Cirò 2
Cologno Monzese 2
Espoo 2
Frankfurt am Main 2
Fremont 2
Gualtieri 2
Lappeenranta 2
Lizzanello 2
London 2
Maricopa 2
Marigliano 2
Totale 4.677
Nome #
Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis 136
Hemolytic anemia during pegylated interferon alpha 2b plus ribavirin treatment for chronic hepatitis C: ribavirin is not always the culprit. A case report 78
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 71
Successful treatment of post-surgical osteomyelitis caused by XDR Pseudomonas aeruginosa with ceftolozane/tazobactam monotherapy 70
CpG and Toll-like receptor 9 in primary biliary cirrhosis: a possible intracellular interaction from virus exposure? 66
The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C 65
HIV and hepatitis C virus: facts and controversies 62
A survey on antibiotic therapy knowledge among physicians of a tertiary care and university hospital 61
Rara e grave manifestazione dell’infezione da HHV-6: la sindrome DRESS. 60
CD4+ T lymphocytes and cryoglobulins in patients coinfected with HIV and hepatitis C virus: forgetting the hidden CD4+ cell subsets. 59
Human Platelet Antigen Genotypes As Predictors of Liver Cirrhosis In Patients With Hcv Chronic Infection 59
Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art 59
A SIMPLE NONINVASIVE SCORE PREDICTS GASTROESOPHAGEAL VARICES IN PATIENTS WITH CHRONIC VIRAL HEPATITIS. 58
Asunaprevir for hepatitis C: A safety evaluation 58
A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C 57
Discontinued drugs in 2012 - 2013: Hepatitis C virus infection 57
Does compulsory vaccination limit personal freedom? Ethical issues 56
Febbre di origine sconosciuta (FUO): nostra casistica 54
Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection 54
A Novel Promising Therapeutic Option Against Hepatitis C Virus: An Oral Nucleotide NS5B Polymerase Inhibitor Sofosbuvir 53
HCV and GBV-c/HGV infection in HIV positive patients in southern Italy. 50
Human Platelet Antigen 3 Genotype Is An Independent Predictor of Platelet Count In Patients With Chronic Hepatitis C 50
Low vitamin D levels are associated with the presence of serum cryoglobulins in patients with chronic HCV infection 50
A CASE OF PEGYLATED INTERFERON ALPHA-RELATED DIABETIC KETOACIDOSIS: CAN THIS COMPLICATION BE AVOIDED? 49
Current and emerging pharmacotherapy for the treatment of bacterial peritonitis 49
Antibiotic prophylaxis and risk of infections in thyroid surgery: Results from a national study (UEC - Italian Endocrine Surgery Units Association) 49
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 48
Specific immunoglobulin against HCV: new perspectives. 48
ABT-450: A novel protease inhibitor for the treatment of hepatitis C virus infection 48
The serum-ascites vitamin D gradient (SADG): A novel index in spontaneous bacterial peritonitis 48
Human immunodeficiency virus and subtype 1B hepatitis C virus: more similarities than differences in T-helper subsets. 47
Homocysteine levels and sustained virological response to pegylated-interferon alpha2b plus ribavirin therapy for chronic hepatitis C: a prospective study. 47
Prevalenza di infezioni da CMV, HHV-6 o EBV in bambini con disturbi dello spettro autistico. 47
Exposure to Varicella Zoster Virus is higher in children with autism spectrum disorder than in healthy controls. Results from a case-control study. 47
Concomitant Interferon-alfa and chemotherapy in hepatitis C and colorectal cancer: a case report 46
Beclabuvir for the treatment of hepatitis C 46
The efficacy and safety of telaprevir - a new protease inhibitor against hepatitis C virus. 45
Current evidence on the management of hepatitis B in pregnancy 45
Studio sulla conoscenza dell’antibioticoterapia tra i medici di un ospedale universitario di terzo livello 45
Investigational direct-acting antivirals in hepatitis C treatment: The latest drugs in clinical development 45
Hepatitis C screening in the Emergency Department of a large hospital in southern Italy: results of a pilot study 45
Mutante lamivudino-resistente in paziente in profilassi con lamivudina in corso di chemioterapia antiblastica per linfoma non-Hodgkin: recupero clinico con terapia di associazione lamivudina e adefovir. 44
Blood letting therapy in HCV-related iron overload - Part 1: Evaluation of clinical, hematological and hepatic parameters 44
Blood In Saliva of Patients With Acquired-immunodeficiency-syndrome - Possible Implication In Sexual Transmission of the Disease 44
Blood in saliva of HIV seropositive drug abusers: possible implication in AIDS transmission. 44
Human platelet antigen 3 genotype predicts platelet count in patients with HCV infection 44
Daclatasvir: The First of a New Class of Drugs Targeted Against Hepatitis C Virus NS5A 44
Prevalence and risk factors of erectile dysfunction in patients with hepatitis B virus or hepatitis C virus or chronic liver disease: Results from a prospective study 44
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 44
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 44
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 44
Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort) 44
TNF-alpha serum level elevations in chronic hepatitis C patients with diabetes mellitus. 43
Human immunodeficiency virus per se exerts atherogenic effects. 43
Blood letting therapy in HCV-related iron overload - Part 2: Evaluation of HFE genetic mutation, HCV genotype and viral load 43
Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection. 43
Direct acting antiviral agents and hepatocellular carcinoma development: Don't take it for granted 43
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 43
Fecal microbiota transplantation for Clostridium difficile infection: Back to the future 42
Bacterial and CMV pneumonia in a patient treated with alemtuzumab for multiple sclerosis 42
Immunoglobulin superantigen protein L induces IL-4 and IL-13 secretion from human Fc epsilon RI+ cells through interaction with the kappa light chain of IgE 41
Detection of Hepatitis-c Virus-rna By Polymerase Chain-reaction In Dental Surgeries 41
Anti-HBc positivity was associated with histological cirrhosis in patients with chronic hepatitis C. 41
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 41
Compromissione cognitiva subclinica in pazienti HCV-positivi 40
Prevalence of circulating immunecomplexes and variations of complement fractions in HBV, HDV and HCV infections: statistical analysis and clinical correlations. 40
A pill a day keeps HCV away 40
Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trial. 39
[Effect of the administration of Cardiostenol on experimental hepatitis in mice induced with MHV-3 virus]. 39
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naive for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004-2014 39
A RARE CASE OF BRAINSTEM ENCEPHALITIS BY LISTERIA MONOCYTOGENES WITH ISOLATED MESENCEPHALIC LOCALIZATION. CASE REPORT AND REVIEW. 38
[Effect of cocaine administration on experimental hepatitis in the mouse caused by MHV-3 virus: preliminary results]. 38
Current concepts and future strategies in the antimicrobial therapy of emerging Gram-positive spontaneous bacterial peritonitis 38
Prevalence of HSV1/2 congenital infection assessed through genome detection on dried blood spot in individuals with autism spectrum disorders 38
Epidemiology and Microbiology of Skin and Soft Tissue Infections: Preliminary Results of a National Registry 38
Long-term interferon-alpha therapy does not affect sex hormones in males with chronic hepatitis C. 37
Iron depletion before HCV antiviral therapy: A pilot, randomized, controlled trial. 37
Aetiological association of virus like particles with hepatitis C. 37
[Clinical and diagnostic considerations on a case of pancreatic plasmacytoma]. 37
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens 37
Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn's disease 37
Immune system homeostasis during acute hepatitis C: viral escape or T-cell regulation? 36
Uno score non invasivo può predire la presenza di varici gastroesofagee nei pazienti con epatopatia cronica virale. 36
Diffusione dell'infezione da virus epatitico B in ambiente odontoiatrico 36
Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world? 36
Sustained low influenza vaccination in health care workers after H1N1 pandemic: A cross sectional study in an Italian health care setting for at-risk patients 36
Decreased warfarin effects in elder with recurrent Clostridium difficile infection during fidaxomicin therapy: a case report 36
Infections worsen prognosis of patients with cirrhosis irrespective of the liver disease stage 36
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 36
Multivariate discriminant function based on six biochemical markers in blood can predict the cirrhotic evolution of chronic hepatitis. 35
Contaminazione da HBsAg (antigene di superficie del virus epatitico B) in ambiente odontoiatrico 35
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 35
Myasthenia gravis during low-dose IFN-alpha therapy for chronic hepatitis C. 34
Tenofovir and its potential in the treatment of hepatitis B virus 34
[Demonstration of the interchangeability of 2 types of recombinant anti-hepatitis-B vaccine]. 34
Ultrastructural effects of PCMS on mycelial-yeast transition in Histoplasma capsulatum. 34
Prevalence of hepatitis C virus genotypes in southern Italy 34
Acute hepatitis C in patients undergoing hemodialysis: experience with high-dose interferon therapy 34
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program 34
The therapeutic potential of new investigational hepatitis C virus translation inhibitors 34
Totale 4.591
Categoria #
all - tutte 38.050
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.050


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020249 0 0 0 0 0 0 0 6 6 43 114 80
2020/2021350 29 22 37 24 37 70 30 3 36 18 32 12
2021/20221.113 5 3 0 6 4 31 5 38 176 79 210 556
2022/20231.705 234 86 24 135 162 182 13 241 254 287 57 30
2023/2024950 35 160 217 40 35 64 19 85 9 16 165 105
2024/20251.922 330 382 13 95 144 263 561 134 0 0 0 0
Totale 7.740